Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Early research (Phase 1)Ended earlyNCT03220347
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinNeoplasms
Celgene 139
Testing effectiveness (Phase 2)Study completedNCT00002955
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
University of Southern California 21
Early research (Phase 1)Study completedNCT02723955
What this trial is testing

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

Who this might be right for
Neoplasms
GlaxoSmithKline 829
Early research (Phase 1)Not Yet RecruitingNCT07716735
What this trial is testing

Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

Who this might be right for
Advanced Kidney CarcinomaAdvanced Renal Cell CarcinomaHereditary Leiomyomatosis and Renal Cell Carcinoma+6 more
Jonsson Comprehensive Cancer Center 18
Early research (Phase 1)Study completedNCT00335998
What this trial is testing

Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies

Who this might be right for
Recurrent Cervical CancerRecurrent Ovarian Epithelial CancerRecurrent Vaginal Cancer+15 more
National Cancer Institute (NCI) 24
Post-approval studies (Phase 4)Ended earlyNCT06077487
What this trial is testing

Ketamine-assisted Therapy for Advanced GI Cancer

Who this might be right for
Pancreatic Ductal AdenocarcinomaPain, AcuteGastrointestinal Cancers+1 more
Brian Anderson, MD 1
Early research (Phase 1)Study completedNCT00006221
What this trial is testing

BMS-247550 in Treating Patients With Advanced Cancers

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 54
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Testing effectiveness (Phase 2)Study completedNCT01138904
What this trial is testing

FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)

Who this might be right for
Gastric Cancer
Dong-A University Hospital 80
Early research (Phase 1)Looking for participantsNCT07182149
What this trial is testing

NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Who this might be right for
HNSCCESCCEsophageal Adenocarcinoma+7 more
Normunity AccelCo, Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT07309185
What this trial is testing

Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line Therapy

Who this might be right for
Stomach Neoplasms
Shandong Tumor Hospital 66
Testing effectiveness (Phase 2)Looking for participantsNCT07699185
What this trial is testing

Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tongji Hospital 336
Large-scale testing (Phase 3)Study completedNCT00212615
What this trial is testing

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
C04.588.274.476.411.307
Odense University Hospital 116
Testing effectiveness (Phase 2)Looking for participantsNCT06567015
What this trial is testing

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Pierre Fabre Medicament 171
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Early research (Phase 1)Study completedNCT00084708
What this trial is testing

Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 53
Early research (Phase 1)Ended earlyNCT04810208
What this trial is testing

Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor
Lidds AB 6
Testing effectiveness (Phase 2)Study completedNCT00714025
What this trial is testing

A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy

Who this might be right for
Transitional Cell Carcinoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 40
Testing effectiveness (Phase 2)Study completedNCT00890825
What this trial is testing

AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 88
Next Page